Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Merck’s Q1 sales drop

April 30, 2014 Sales and Marketing AstraZeneca, Merck, Pfizer, Q1, merger, quarter, sales

Merck & Co has released a mixed set of results for the first quarter of 2014, with drug revenue falling …
News

FDA approves Zykadia for late-stage lung cancer

April 30, 2014 Research and Development, Sales and Marketing Cancer, FDA, Novartis, lung, zykadia

Novartis’ ‘breakthrough’ drug Zykadia has been approved by the FDA to treat lung cancer patients with a particular genetic mutation. …
News

Lonza makes change at the top

April 30, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, funk

Swiss pharma supplier firm Lonza has confirmed a leadership change as its chief operating officer (COO) leaves.  Marc Funk has …
Appointment

Cancer Research funding to be doubled

April 30, 2014 Research and Development, Sales and Marketing CRUK, Cancer, brain, breast, funding, lung

Cancer Research UK is to increase its research funding by 50% over the next decade as part of a new strategy …
News

Facebook dementia app created

April 29, 2014 Medical Communications, Sales and Marketing Alzheimer's, Facebook, app, dementia

Alzheimer’s Research UK has launched a new Facebook app which allows users to see what it is like to suffer …
News

‘Transformational’ NHS social media tool launches

April 29, 2014 Medical Communications, Sales and Marketing NHS, digital, healthberry, king, social media

London-based startup firm HealthBerry has developed a social media web and mobile application that is set to transform how the …
News

Pfizer ‘significantly undervalued’ AstraZeneca

April 29, 2014 Sales and Marketing AstraZeneca, Pfizer, acquisition, buyout, merger

AstraZeneca has broken its silence to insist that Pfizer’s financial offer in January for the company “very significantly undervalued AstraZeneca …
News

PrimeVigilance appoints chief medical officer

April 29, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing primevigilance, seebeck

Pharmacovigilance and medical services firm PrimeVigilance has appointed Dr Joerg Seebeck as its chief medical officer.  Seebeck is to head …
Appointment

Humira drives AbbVie again

April 28, 2014 Sales and Marketing AbbVie, Abbott, Humira, RA

Rheumatoid arthritis treatment Humira has once more driven AbbVie, bringing in more than half the company’s sales in the first …
News

NICE chair: pharma must show how it prices drugs

April 28, 2014 Research and Development, Sales and Marketing Goldacre, Haslam, NICE, VBP, all trials, pars

The pharmaceutical industry must be willing to show the public how it prices its drugs – or face losing its …
News

Pfizer makes second bid for AstraZeneca

April 28, 2014 Research and Development, Sales and Marketing AstraZeneca, Pfizer, acquisition, deal, merger

Pfizer has made a second attempt to buy AstraZeneca after an initial request was rejected in January. The biggest pharma …
News

Brazil focus: not just another BRIC in the wall

April 28, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BRIC, Brazil, emerging markets, market access, rio

Population: 198.7 million (2012) Government: Federal presidential republic Leader: President Dilma Rousseff of the centre-left Workers’ Party Gross Domestic Product: …
Feature

reViral hires non-executive director

April 28, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing reviral, schinazi

Antiviral drug firm reViral has appointed Professor Raymond 
Schinazi as a non-executive director.  Schinazi has had a long and prestigious …
Appointment

Mekinist shown green light by CHMP

April 28, 2014 Sales and Marketing CHMP, Cancer, GSK, mekinist, oncology, trametinib

GlaxoSmithKline’s melanoma drug Mekinist is virtually nailed on to be given approval in the European Union following a positive opinion …
News

Novartis reports healthy profit

April 25, 2014 Sales and Marketing Afinitor, Gleevec, Glivec, Novartis, Q1, lilly

Multiple sclerosis drug Gilenya and cancer treatment Afinitor were among the biggest sellers for Novartis, as the Swiss company’s net …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026